[Treatment with avafortan, a new spasmolytic & analgesic].
D000700:Analgesics; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D058633:Antipyretics; D004177:Dipyrone; D004338:Drug Combinations; D005998:Glycine / Q000031:analogs & derivatives; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010276:Parasympatholytics; D010648:Phenylacetates; D013035:Spasm / Q000628:therapy*
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D004338:Drug Combinations; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D010648:Phenylacetates; C038564:camylofin, dipyrone drug combination; D004177:Dipyrone; D005998:Glycine
ANALGESICS AND ANTIPYRETICS/therapeutic use; MUSCLE RELAXANTS/therapeutic use; SPASM/therapy
Ein Beitrag zur Behandlung mit einem neuartigen Spasmolyticum und Analgeticum (Avafortan).